AND APPROACHES

to study issues associated with professional practice as they relate to pharmaceutical education, and to establish and improve working relationships with all other organizations in the field of health affairs. The Committee is also encouraged to address related agenda items relevant to its Bylaws charge and to identify issues for consideration by subsequent committees, task forces, commissions, or other groups. Following an organizational telephone conference call in September, the committee members were requested by the committee chair to identify one or more key issues which addressed the above charges. These issues were collected and grouped by the chair and given priority scores by committee members in a single round of ranking. The composite rankings were shared with committee members at the October 30, 1994 meeting and served as the basis for focusing the committee’s discussions